trastuzumab,neratinib
roche,puma
['summit', 'breast', 'pbyi', 'puma']
$pbyi puma biotechnology presents outcomes from the metastatic breast cancer cohort of the summit trial at the asco 2022 annual meeting - 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities